SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Clinical Drug Research – Diabetes and Obesity
View Sample

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 5
eBook: US $69 Special Offer (PDF + Printed Copy): US $126
Printed Copy: US $91
Library License: US $276
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-68108-754-2 (Print)
ISBN: 978-1-68108-753-5 (Online)
Year of Publication: 2020
DOI: 10.2174/97816810875351190501
Rate This Book

Introduction

Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The fifth volume of this series features 5 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist.

-Metabolic syndrome in schizophrenia

-Insulin therapy and foetoplacental endothelial dysfunction in gestational diabetes mellitus

-Insights on diabetes, oxidative stress and antioxidant therapeutic strategies

-Administration of nano drugs in the treatment of diabetes mellitus

-SGLT-2 inhibitors


eBook: US $69 Special Offer: US $126 Printed Copy: US $91 Library License: US $276

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK



Contributor(s):
Roberto Mandrioli
Department for Life Quality Studies
Alma Mater Studiorum – University of Bologna
Rimini
Italy


Michele Protti
Pharmaco-Toxicological Analysis Laboratory (PTA Lab)
Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum - University of Bologna
Bologna
Italy


Laura Mercolini
Pharmaco-Toxicological Analysis Laboratory (PTA Lab)
Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum - University of Bologna
Bologna
Italy


Mario Subiabre
Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics, Division of Obstetrics and Gynaecology, School of Medicine
Faculty of Medicine, Pontificia Universidad Católica de Chile
Santiago 8330024
Chile


Roberto Villalobos-Labra
Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics, Division of Obstetrics and Gynaecology, School of Medicine
Faculty of Medicine, Pontificia Universidad Católica de Chile
Santiago 8330024
Chile


Luis Silva
Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics, Division of Obstetrics and Gynaecology, School of Medicine
Faculty of Medicine, Pontificia Universidad Católica de Chile
Santiago 8330024
Chile
/
Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology
University of Groningen, University Medical Centre Groningen (UMCG)
Groningen 9700 RB
The Netherlands


Fabián Pardo
Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics, Division of Obstetrics and Gynaecology, School of Medicine
Faculty of Medicine, Pontificia Universidad Católica de Chile
Santiago 8330024
Chile
/
Metabolic Diseases Research Laboratory, Center of Research, Development, and Innovation in Health - Aconcagua Valley
San Felipe Campus, School of Medicine, Faculty of Medicine, Universidad de Valparaíso,
2172972 San Felipe
Chile


Luis Sobrevia
Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics, Division of Obstetrics and Gynaecology, School of Medicine
Faculty of Medicine, Pontificia Universidad Católica de Chile
Santiago 8330024
Chile
/
Department of Physiology
Faculty of Pharmacy, Universidad de Sevilla
Seville E-41012
Spain
/
University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine and Biomedical Science
University of Queensland, Herston, QLD 4029
Queensland
Australia


Nicolette Nadene Houreld
Laser Research Centre
Faculty of Health Sciences, University of Johannesburg
Johannesburg, 2028
South Africa


Naresh Kumar Rajendran
Laser Research Centre
Faculty of Health Sciences, University of Johannesburg
Johannesburg, 2028
South Africa


Radhika Tippani
Department of Biotechnology
Kakatiya University, Warangal, 506009
Telangana State
India


Rama Narsimha Reddy Anreddy
Department of Pharmacology, Jyothishmathi Institute of Pharmaceutical Sciences
Ramakrishna Colony, Thimmapur, Karimnagar 505481
Telangana State
India


Mahendar Porika
Department of Biotechnology
Kakatiya University, Warangal, 506009
Telangana State
India


Siddhartha Dutta
All India Institute of Medical Sciences
Jodhpur
Rajasthan
India


Pramod Kumar Sharma
All India Institute of Medical Sciences
Jodhpur
Rajasthan
India


Arup Kumar Misra
All India Institute of Medical Sciences
Jodhpur
Rajasthan
India



RELATED BOOKS

.Natural Products in Clinical Trials.
.Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook.
.Natural Products in Clinical Trials.
.Advances in Physicochemical Properties of Biopolymers: Part 1.